Expo

We’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston Convention & Exhibition Center.

We are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025, at the Palacongressi di Rimini.

Anemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on gene therapy in Gaithersburg, MD.

​Anemocyte is excited to announce its participation as an attendee at TIDES USA 2025, taking place from May 19–22, 2025, at the Manchester Grand Hyatt in San Diego, California.

Anemocyte announces its sponsorship and exhibition at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), from May 13–17, 2025.

Anemocyte is excited to announce its participation as an exhibitor at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, taking place from May 7 to 10 in New Orleans, Louisiana.

Anemocyte is pleased to announce its participation in the Cell & Gene Meeting on the Med 2025, taking place from April 15th to 17th at the Rome Cavalieri in Rome.

Anemocyte is excited to announce its participation in CPHI Japan 2025, taking place from April 9th to 11th at Tokyo Big Sight in Halls East 4, 5, and 6.

The international BIO-Europe Spring® conference is now in its 19th year and this year will take place in Milan at Allianz MiCo from March 17-19, 2025.

The symposium will be held in Rimini, Italy, March 17-19, involving all researchers conducting research in the field of rare genetic diseases with the Fondazione Telethon’s support.